Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Top Cited Papers
Open Access
- 4 April 2011
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 5 (3) , S9-S17
- https://doi.org/10.1016/j.jacl.2011.03.452
Abstract
No abstract availableFunding Information
- Takeda Pharmaceutical Company
This publication has 65 references indexed in Scilit:
- PCSK9: a convertase that coordinates LDL catabolismJournal of Lipid Research, 2009
- Long-term prognostic factors of young patients (≤ 35 years) having acute myocardial infarction: the detrimental role of continuation of smokingEuropean Journal of Preventive Cardiology, 2008
- Lipid Screening and Cardiovascular Health in ChildhoodPediatrics, 2008
- Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysisBMJ, 2007
- Molecular biology of PCSK9: its role in LDL metabolismTrends in Biochemical Sciences, 2007
- Cascade genetic screening for familial hypercholesterolemiaClinical Genetics, 2004
- Lipid Disorders and Mutations in the APOB GeneClinical Chemistry, 2004
- Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in UtahThe American Journal of Cardiology, 1993
- Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular geneticsPublished by Elsevier ,1993
- Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial HypercholesterolemiaNew England Journal of Medicine, 1987